MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

PBM — Psyence Biomedical Ltd. Common Shares

Nasdaq

Psyence Biomedical Ltd. Common Shares

CompareBack to Screener
$4.88
-0.14(-2.79%)
O
4.93
H
5.10
L
4.84
V
16.2K
⏱️ End-of-day dataAs of Oct 7, 2026

Chart

About PBM

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

IndustryCommon Stock
SectorNot available
IPO DateJan 26, 2024
Employees12
Stock ExchangeNasdaq
Ticker SymbolPBM

Key Financial Statistics

Market Cap$19.68M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.92 - $175.78
52-Week Avg Volume728.7K
VWAP$4.92
Transactions257
Total Recorded Bars1,210 days